Stanley A. Knight

Stanley Allen Knight serves as a Contracting Officer responsible for managing complex procurements in support of scientific, technical, and pharmaceutical initiatives. In this role, he ensures compliance with federal acquisition regulations while advancing mission-critical objectives through strategic sourcing, competitive bidding, and contract administration. His portfolio primarily encompasses research and development services, medicinal manufacturing, and specialized professional technical services, requiring deep familiarity with technical specifications, performance-based contracting, and lifecycle management of high-value procurements. Knight’s work is instrumental in translating agency needs into legally sound, transparent, and efficient acquisition outcomes. Knight maintains a broad network of vendors across the life sciences and professional services sectors, engaging with both large prime contractors and niche suppliers capable of delivering specialized scientific solutions. His contracting patterns reflect a preference for open competition, with no set-asides currently utilized in his award portfolio. This approach emphasizes merit-based selection, ensuring that contracts are awarded to the most qualified offerors regardless of socioeconomic status, while still adhering to all applicable small business goals and reporting requirements. His set-aside preferences are uniformly non-reserved, with 100% of his acquisitions conducted under full and open competition. While he does not prioritize 8(a), HUBZone, or SDVOSB set-asides, his contracting process remains fully compliant with socioeconomic program objectives, and small businesses are encouraged to compete on an equal footing through transparent solicitation practices and clear evaluation criteria. Knight’s primary procurement focus lies in NAICS 325411 (Medicinal and Botanical Manufacturing), NAICS 541990 (All Other Professional, Scientific, and Technical Services), and NAICS 541712 (Research and Development in the Physical, Engineering, and Life Sciences). He regularly acquires pharmaceutical formulations, laboratory testing services, clinical research support, and specialized analytical instrumentation, demonstrating expertise in regulated, compliance-driven domains requiring rigorous technical oversight and quality assurance protocols.